HMD indigenously develops revolutionary Dispojekt safety needle syringes to curb the menace of NSI

Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable and Autodisable syringes in the world, has launched the most innovative and first-of-its kind Dispojekt single use syringes with safety needle, which further strengthens India's position in becoming global powerhouse in medical devices. With the revolutionary Dispojekt safety syringes, HMD aims to reduce prevalence of accidental Needle Stick Injuries (NSIS) among health workers, reduction of infection control cost and that of disposal and training, offering a long term positive financial impact on the healthcare sector.

Domestic manufactured, technologically advanced product will provide India global edge in the realm of R&D and leapfrog indigenous players to meet the highly demanding global market for sharp injury prevention syringes.

The use of safety needles in healthcare settings offer numerous cost benefits. They reduce healthcare worker injuries, lowering costs from potential disease treatment and potential long-term health issues. By minimizing needle stick injuries, they also decrease expenses for postexposure prophylaxis and associated healthcare costs. Moreover, safety needles mitigate compensation claims, absenteeism, and can lead to lower health insurance premiums, while also reducing product and packaging footprints for cost and environmental savings. They assist in creating a safer and more reliable workplace environment for healthcare workers. “Equipped with a safety shield (SIP Shield), Dispojekt syringe addresses critical concerns of needle stick injuries and reaffirms our commitment as market leader towards excellence in healthcare. It is a great outcome of our Make in India resolve as envisioned by Prime Minister Narendra Modi to realize the goal of Viksit Bharat,” said Mr Rajiv Nath, Managing Director, HMD, adding that

India is all poised to become global powerhouse in manufacturing and exporting of medical devices in sync with the spirit of Atma Nirbhar Bharat.

There is significant headroom for innovation and growth in medical devices industry and the future of healthcare technology rests on robust R&D. With the disposable syringe market size in India estimated to be over 5 billion units per year and 5-6 billion needle, and 80 % of which in the hands of private sector players. “We aim for 60-70 % market share in the next three years, thanks to our innovative Dispojekt,” informed the Executive Director, Mr Sohail Nath. “HMD believes in delivering the best at the most competitive costing. Dispojekt safety needle syringes are going to be the game changer in the Global fight against NSIS. We are aiming to initially produce 200 million syringes and needles per annum for which we have invested approximately Rs 70 cr in the first phase,” revealed Mr Sohail. “In the second phase, we will increase the capacity to 300 million pieces per annum by investing another Rs 10 crore to Rs 15 crore,” added Mr Sohail, sounding buoyant over expected return on investment over the next five years as HMD is a debt-free financially strong manufacturer and the product development has been financed from internal resources without any grants. As one of the most reputed medical device manufacturers with multiple stateof-the-art manufacturing facilities in Faridabad, Haryana, HMD produces over 4 billion injection needles per annum, catering to the needs of its primary markets comprising India, Europe, US, Middle East, and its secondary markets of South-east Asia and Africa.